Chem. Biodiversity 2021, 18, e2000772
References
11β-HSD1 Enzyme Activity Assay
[1] M. Wamil, J. R. Seckl, ‘Inhibition of 11β-hydroxysteroid
dehydrogenase type 1 as a promising target’, Drug
Discovery Today 2007, 12, 504–520.
[2] S. M. Grundy, H. B. Brewer, J. I. Cleeman, S. C. Smith, C.
Lenfant, ‘Definition of metabolic syndrome: report of the
national heart, lung, and blood institute/American heart
association conference on scientific issues related to
definition’, Circulation 2004, 109, 433–438.
[3] J. S. Scott, F. W. Goldberg, A. V. Turnbull, ‘Medicinal
chemistry of inhibitors of 11β-hydroxysteroid dehydrogen-
ase type 1(11β-HSD1)’, J. Med. Chem. 2014, 57, 4466–4486.
[4] W. Sun, X. T. Chen, Q. Y. Tong, H. C. Zhu, Y. He, L. Lei, Y. B.
Xue, G. M. Yao, Z. W. Luo, J. P. Wang, H. Li, Y. H. Zhang,
‘Novel small molecule 11β-HSD1 inhibitor from the
endophytic fungus Penicilliun commune’, Sci. Rep. 2016, 6,
26418.
[5] X. H. Yan, P. Yi, P. Cao, S. Y. Yang, X. Fang, Y. Zhang, B. Wu,
Y. Leng, Y. T. Di, Y. Lv, X. J. Hao, ‘16-nor limonoids from
Harrisonia perforata as promising selective 11β-HSD1
inhibitors’, Sci. Rep. 2016, 36927.
[6] Editorial Committee of Flora of China, ‘Flora of China’,
Science Press, Beijing, 1979, 21, 19.
[7] J. H. Xie, M. Y. Shen, S. P. Nie, X. Liu, H. Zhang, M. Y. Xie,
‘Analysis of monosaccharide composition of Cyclocarya
paliurus polysaccharide with anion exchange chromatog-
raphy’, Carbohydr. Polym. 2013, 98, 976–981.
[8] B. Deng, X. L. Shang, S. Z. Fang, Q. Q. Li, X. X. Fu, J. Su, ‘
Integrated effects of light intensity and fertilization on
growth and flavonoid accumulation in Cyclocarya paliurus’,
J. Agric. Food Chem. 2012, 60, 6286–6292.
[9] J. H. Xie, M. Y. Shen, S. P. Nie, M. Y. Shen, Y. X. Wang, C. Li,
‘Isolation, chemical composition and antioxidant activities
of a water-soluble polysaccharide from Cyclocarya paliurus
(Batal.) Iljinskaja’, Food Chem. 2010, 119, 1626–1632.
[10] Y. N. Cao, S. Z. Fang, Z. Q. Yin, X. X. Fu, X. L. Shang, W. X.
Yang, H. M. Yang, ‘Chemical fingerprint and multicompo-
nent quantitative analysis for the quality evaluation of
Cyclocarya paliurus leaves by HPLC-Q-TOF-MS’, Molecules
2017, 1927, 1–16.
The inhibitory activities of the isolated compounds on
human or mouse 11β-HSD1 was evaluated using the
scintillation proximity assay (SPA). The full-length
cDNAs of human or murine11β-HSD1 was isolated
from the cDNA libraries provided by NIH Mammalian
Gene Collection. Then, the cDNAs were cloned into
pcDNA3 expression vectors by PCR. HEK-293 cells were
transfected with the pcDNA3-derived expression plas-
mid and selected by cultivation in the presence of
700 μg/mL of G418. Non-resistant cells were removed
by replacing the cell culture medium every other day
for 12–14 days. The single surviving colony was picked
up and expanded. The microsomal fraction over-
expressing 11β-HSD1 was prepared from the HEK-293
cells, which were stably transfected with either human
or mouse 11β-HSD1. The fraction was then used as the
enzyme source for SPA. Different concentrations of
compound were added to 96-well microtiter plates,
followed by the addition NADPH and [3H] cortisone for
11β-HSD1 assay. The product, [3H] cortisol, was
specifically captured by
a monoclonal antibody
coupled to protein A-coated SPA beads. All tests were
performed for three independent replicates with
glycyrrhizinic acid as a positive control. The %
inhibition was calculated relative to a non-inhibited
control. IC50 (X+SD, n=3) values were calculated by
using Prism Version 4 (GraphPad Software, San Diego,
CA).[28]
Acknowledgments
This work was financially supported by the National
Natural Science Foundation of China (U1802287) and
(32000280), the Ten Thousand Talents Plan of Yunnan
Province for Industrial Technology Leading Talents, the
Major Biomedical Project of Yunnan Province
(2019ZF010), and the State Key Laboratory of Phyto-
chemistry and Plant Resources in West China (P2019-
ZZ02).
[11] C. H. Jiang, N. Yao, Q. Q. Wang, J. H. Zhang, Y. Sun, N. Xiao,
K. Liu, F. Huang, S. Z. Fang, X. L. Shang, B. L. Liu, Y. C. Ni,
Z. Q. Yin, J. Zhang, ‘Cyclocarya paliurus extract modulates
adipokine expression and improves insulin sensitivity by
inhibition of inflammation in mice’, J. Ethnopharmacol.
2014, 153, 344–351.
[12] H. M. Yang, Z. Q. Yin, M. G. Zhao, C. H. Jiang, J. Zhang, P.
Ke, ‘Pentacyclic triterpenoids from Cyclocarya paliurus and
their antioxidant activities in FFA-induced HepG2 steatosis
cells’, Phytochemistry 2018, 151, 119–127.
[13] Y. Liu, M. Q. Zhang, X. L. Li, T. H. Xu, S. X. Xie, Y. J. Xu, D. M.
Xu, ‘Study on chemical constituents of Cyclocarya paliurus’,
J. Asian Nat. Prod. Res. 2014, 16, 206–209.
Author Contribution Statement
[14] R. G. Shu, C. R. Xu, L. N. Ni, ‘Studies on the sweet principles
from the leaves of Cyclocarya paliurus (Batal.) Iljinsk’, Acta
Pharm. Sin. 1995, 30, 757–761.
[15] Z. J. Fang, S. N. Shen, J. M. Wang, Y. J. Wu, C. X. Zhou, J. X.
Mo, L. G. Lin, L. S. Gan, ‘Triterpenoids from Cyclocarya
paliurus that enhance glucose uptake in 3T3-L1 adipo-
cytes’, Molecules 2019, 187, 1–14.
H. Yan, X. Li, W. Ni and Q. Zhao were responsible for
the isolation, structure elucidation and preparing the
manuscript. Y. Leng carried out the bioassays. H.-Y. Liu
designed and supervised this research.
(6 of 7) e2000772
© 2020 Wiley-VHCA AG, Zurich, Switzerland